{{Rsnum
|rsid=5629
|Gene=PTGIS
|Chromosome=20
|position=49513169
|Orientation=minus
|GMAF=0.2222
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=PTGIS
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 8.0 | 29.2 | 62.8
| HCB | 2.2 | 43.1 | 54.7
| JPT | 2.7 | 36.3 | 61.1
| YRI | 2.0 | 23.8 | 74.1
| ASW | 3.5 | 28.1 | 68.4
| CHB | 2.2 | 43.1 | 54.7
| CHD | 4.6 | 39.4 | 56.0
| GIH | 3.0 | 39.6 | 57.4
| LWK | 0.0 | 18.2 | 81.8
| MEX | 8.6 | 37.9 | 53.4
| MKK | 0.6 | 23.7 | 75.6
| TSI | 10.8 | 46.1 | 43.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=19719985
|Title=Resequencing and association study of vesicular glutamate transporter 1 gene (VGLUT1) with schizophrenia
}}

{{PharmGKB
|RSID=rs5629
|Name_s=
|Gene_s=PTGIS
|Feature=Exon/Syn
|Evidence=Web Resource:http://www.pharmgkb.org/search/annotatedGene/ptgis/variant.jsp#ImportantVariantInformationforPTGIS-6
|Annotation=This variant is associated with myocardial infarction and hypertension.
|Drugs=
|Drug Classes=
|Diseases=Hypertension; Myocardial Infarction
|Curation Level=In-Depth
|PharmGKB Accession ID=PA162356240
}}

{{PMID Auto
|PMID=19046748
|Title=Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke.
|OA=1
}}

{{PMID Auto
|PMID=19147528
|Title=Haplotype analysis of the CYP8A1 gene associated with myocardial infarction.
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs5629
|overall_frequency_n=2350
|overall_frequency_d=10758
|overall_frequency=0.218442
|n_genomes=21
|n_genomes_annotated=0
|n_haplomes=21
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}